Chembio Diagnostics, Inc. Sustainability Profile
Chembio Diagnostics, Inc., a leading player in the diagnostics industry, is headquartered in the United States and operates across various regions globally. Founded in 1985, the company has established itself as a pioneer in the development of innovative point-of-care testing solutions, particularly in infectious disease diagnostics. Chembio's core products include rapid tests for diseases such as HIV, syphilis, and malaria, distinguished by their accuracy and speed. The company’s unique dual-path technology enhances test performance, setting it apart in a competitive market. With a commitment to improving patient outcomes, Chembio has achieved significant milestones, including partnerships with global health organisations. Recognised for its contributions to public health, Chembio Diagnostics continues to strengthen its market position through ongoing research and development, ensuring it remains at the forefront of diagnostic innovation.
DitchCarbon Score
How does Chembio Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Chembio Diagnostics, Inc.'s score of 25 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Chembio Diagnostics, Inc.'s reported carbon emissions
Chembio Diagnostics, Inc., headquartered in the US, currently does not have available emissions data for the most recent year. As a result, specific figures regarding their carbon emissions, including Scope 1, 2, and 3 totals, are not provided. The company is a current subsidiary of Biosynex SA, which may influence its climate commitments and emissions reporting. However, there are no documented reduction targets or climate pledges from Chembio Diagnostics, Inc. at this time. In the context of the industry, it is essential for companies like Chembio to establish clear climate commitments and reduction initiatives to align with global sustainability goals. As the landscape of corporate responsibility evolves, the pressure to disclose emissions data and set reduction targets is increasing, making it crucial for Chembio to consider future commitments in this area.
How Carbon Intensive is Chembio Diagnostics, Inc.'s Industry?
How Carbon Intensive is Chembio Diagnostics, Inc.'s Location?
Chembio Diagnostics, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Chembio Diagnostics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Shanghai Kehua Bio-Engineering Co.,Ltd
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.